Acceptable risk of therapies for psoriasis

被引：0
|
作者：
Margolis, D [1 ]
Filip, J [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2004年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
354
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [21] BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS
    Dotan, A.
    Ben-Shabat, N.
    Mcgonagle, D.
    Amital, H.
    Watad, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1148 - 1149
  • [22] BIOLOGIC THERAPIES FOR PSORIASIS DECREASE THE RISK TO DEVELOP MAJOR DEPRESSIVE DISORDER
    Arnheim, D.
    Dotan, A.
    Ben-Shabat, N.
    Amitale, D.
    Mcgonagle, D.
    Watad, A.
    Weiser, M.
    Amital, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1768 - 1768
  • [23] No increased Risk of severe Infections under Biologic Therapies in Patients with Psoriasis
    Sossau, D.
    Yazdi, A. S.
    HAUTARZT, 2018, 69 (07): : 609 - 610
  • [24] An acceptable risk?
    Pritchard, J
    LAB ANIMAL, 1998, 27 (06) : 14 - 14
  • [25] BIOLOGICS THERAPIES FOR PSORIASIS AND PSORIASIS ARTHRITIS AFFECT ON FUTURE RISK FOR DEVELOPING MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Dotan, A.
    Ben-Shabat, N.
    Mcgonagle, D.
    Watad, A.
    Amital, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1123 - 1124
  • [26] ZERO RISK OR ACCEPTABLE RISK
    GOUGH, M
    AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1991, 52 (10): : A556 - A560
  • [27] Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review)
    Baroiu, Liliana
    Anghel, Lucretia
    Tatu, Alin Laurentiu
    Iancu, Alina Viorica
    Dumitru, Caterina
    Lese, Ana-Cristina
    Draganescu, Miruna
    Nastase, Florentina
    Niculet, Elena
    Fotea, Silvia
    Nechita, Aurel
    Voinescu, Doina Carina
    Stefanopol, Anca Ioana
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (06)
  • [28] Risk of Serious Infections During Use of Biologic Therapies for Psoriasis: A Systematic Review
    Yiu, Zenas Z. N.
    Exton, Lesley S.
    Jabbar-Lopez, Zarif
    Mustapa, M. Firouz Mohd
    Samarasekera, Eleanor
    Burden, David
    Murphy, Ruth
    Owen, Caroline M.
    Parslew, Richard
    Venning, Vanessa
    Ashcroft, Darren M.
    Griffiths, Christopher E. M.
    Smith, Catherine H.
    Warren, Richard B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 517 - 518
  • [29] THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES
    Mason, Kayleigh
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 33 - 33
  • [30] Biologic therapies for psoriasis and eyes
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    Grant-Kels, Jane M.
    Grzybowski, Andrzej
    CLINICS IN DERMATOLOGY, 2023, 41 (04) : 523 - 527
12345